[ad_1] [1/2]A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski/File Photo Acquire Licensing Rights FRANKFURT, Dec 5 (Reuters) – Germany’s…
Tag: RHPI:DRUG-DEVICE-TRIALS
Sanofi looks to widen Dupixent use to treat ‘smoker’s lung’ after second trial win
[ad_1] The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File photo Acquire Licensing Rights Nov 27 (Reuters) –…
Novo to launch Wegovy in Asia with February Japan roll-out
[ad_1] Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights COPENHAGEN, Nov 23…
Novo Nordisk raises full-year guidance again as US sales of Wegovy, Ozempic fly
[ad_1] [1/2]A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights…
Nobel Prizes: Kariko and Weissman, pioneers of COVID vaccine, win medicine award
[ad_1] Kariko and Weissman were pioneers of COVID-19 shots Scientists win first 2023 Nobel prize and $1 million Pair lauded for helping save millions of lives STOCKHOLM, Oct 2 (Reuters)…
Novo Nordisk to launch Wegovy in more countries in ‘constrained’ manner – CEO
[ad_1] CEO of Novo Nordisk Lars Fruergaard Jorgensen is seen during the 6th edition of the “Choose France” Summit at the Chateau de Versailles, outside Paris on May 15, 2023.…
Sanofi reaffirms target to deliver over $10.9 bln in annual vaccine sales by 2030
[ad_1] June 29 (Reuters) – French drugmaker Sanofi (SASY.PA) on Thursday reaffirmed its ambition to deliver more than 10 billion euros ($10.89 billion)in annual vaccines sales by 2030, driven by…
US FDA panel backs restricted use of AstraZeneca’s prostrate cancer drug
[ad_1] April 28 (Reuters) – A panel of U.S. Food and Drug Administration advisers on Friday voted for the restricted use of British drugmaker AztraZeneca Plc’s (AZN.L) experimental treatment, jointly…
Novo Nordisk to slash US insulin prices, following move by Eli Lilly
[ad_1] March 14 (Reuters) – Novo Nordisk (NOVOb.CO) said on Tuesday it would cut U.S. list prices for several insulin products by up to 75% next year, joining rival Eli…